We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

No One Size Fits All: The Challenges of Vendor Agnostic Software
Industry Insight

Biosero, Inc. develop automation software, that deploys artificial intelligence to speed up critical lab work. We caught up with David Dambman, Biosero’s Director of Engineering, to talk about the challenges of developing agnostic software, and how labs can implement artificial intelligence into their processes.

Read More

Developing Scalable Flow Chemistry for a Variety of Chemical Transformations
Industry Insight

We recently spoke to Oliver Kappe to learn more about his research. Kappe highlights the key properties of continuous-flow microreactors that make them well-suited to preparing pharmaceuticals.

Read More

Tiny Protein Has Huge Potential in CRISPR
Industry Insight

Last year the smallest CRISPR protein, Cas14 was discovered. We spoke to the scientists that made the discovery, Lucas Harrington, at Mammoth Biosciences, to learn more about Cas14.

Read More

IEX Chromatography Leading the Charge in Charge Variant Analysis
Industry Insight

Find out how the biopharmaceutical industry has benefited from advances in chromatography technology, with insights from Matthew Lauber, consulting scientist at Waters.

Read More

Automated Microfluidic Systems for Gene Editing
Industry Insight

Recently, Oxford Genetics and Sphere Fluidics announced a multi-partner collaboration to expedite the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cells. We spoke with Emily Leproust, PhD, CEO of Twist Biosciences, and other collaborators from the partnership to discuss the background of this announcement and the need for automated systems in gene editing.

Read More

Tailoring Flow Reactor Equipment to the Particular Chemistry at Hand
Industry Insight

We recently spoke to André de Vries from InnoSyn BV to learn more about the considerations to make when scaling up chemical processes. He outlines the advantages of flow chemistry over batch processes and discusses how to design and manufacture flow reactors for any type of chemistry.

Read More

Take a Good Book Around
Industry Insight

Our recent social media poll on "book recommendations for scientists" provided an incredible response. We decided to collate this information and give you the perfect excuse to treat yourself to a new read. Enjoy!

Read More

Breath Test for Cancer: Biomarker Screening is Underway
Industry Insight

The thought that compounds in the breath could be measured and assessed to diagnose different aspects of pathology is an exciting prospect. To learn more about the breathalyzer platform being used in clinical trials to detect early cancer biomarkers, we spoke to Chris Claxton, head of investor relations at Owlstone Medical.

Read More

Superficial Radiation Therapy: A Non-surgical Treatment for Non-melanoma Skin Cancers
Industry Insight

Skin cancer can be broadly split in to two types: melanoma and non-melanoma. The most common non-melanomas include basal cell carcinoma and squamous cell carcinoma, for which the main treatment is surgery. However, other non-surgical options are emerging, including superficial radiation therapy (SRT), a unique type of photon radiotherapy.

Read More

The Vision for Multi-organ Human-on-a-Chip Models
Industry Insight

The development of organ-on-a-chip models aims to reduce the (expensive) high drug failure rates that exist in clinical trials. A Florida biotech firm recently reported that their multi-organ “human-on-a-chip” system maintains cellular viability over 28 days in serum-free conditions, using a pumpless system. To learn more about the vision for multi-organ “human-on-a-chip” models, we caught up with James Hickman, Chief Science Officer of Hesperos Inc.

Read More

 
Advertisement